Reaktionsgleichung
[CH:1]([C:4]1[C:5](=[O:20])[NH:6][C:7](=[O:19])[NH:8][C:9]=1[S:10][C:11]1[CH:16]=[C:15]([CH3:17])[CH:14]=[C:13]([CH3:18])[CH:12]=1)([CH3:3])[CH3:2].C1(C)C(S(O[CH2:31][CH2:32][CH:33]2[CH2:37][CH:36]=[CH:35][CH2:34]2)(=O)=O)=CC=CC=1>>[CH:33]1([CH2:32][CH2:31][N:8]2[C:9]([S:10][C:11]3[CH:12]=[C:13]([CH3:18])[CH:14]=[C:15]([CH3:17])[CH:16]=3)=[C:4]([CH:1]([CH3:3])[CH3:2])[C:5](=[O:20])[NH:6][C:7]2=[O:19])[CH2:37][CH:36]=[CH:35][CH2:34]1Komponenten
3
Versuchsvorschrift
5-Isopropyl-6-(3,5-dimethylphenylthio)-2,4-pyrimidinedione and 2-(cyclopent 3-en-1-yl)ethyl toluenesulfonate were reacted by the same method with example 35 to obtain the titled compound (134 mg).
Quellen und Nachweise
- ORD-Eintrag
- ord-adbd1622bf1e41b9a63e8c60ac58fac9
- Quelldatensatz
- uspto-grants-1999_07
- Patentnummer
- US05922727
Verknüpfte Notizen
Wird geladen…